ORIFARM GROUP A/S — Credit Rating and Financial Key Figures

ORIFARM GROUP A/S (CVR number: 27347282K) is a company from ODENSE. The company reported a net sales of 2014.9 mEUR in 2025, demonstrating a growth of 11 % compared to the previous year. The operating profit percentage was at 4.8 % (EBIT: 96.5 mEUR), while net earnings were 51.8 mEUR. The profitability of the company measured by Return on Assets (ROA) was 8.3 %, which can be considered good and Return on Equity (ROE) was 13.1 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 37 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. ORIFARM GROUP A/S's liquidity measured by quick ratio was 0.7 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.